|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.115 EUR | -0.45% |
|
-5.11% | -24.15% |
| 07-07 | Laboratorio Erfo continues buyback, acquires 15,000 treasury shares | AN |
| 06-29 | Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 3.95M | 4.74M | 4.62M | 7.86M |
Direct | 598K | 500K | 703K | 850K | 1.09M |
Other | - | 457K | 576K | 562K | 672K |
Medical | - | 125K | 244K | 306K | 411K |
Revenues from Services | 1.12K | - | - | - | - |
Wholesale Sales Revenues | 4.07M | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 4.66M | 5.01M | 5.23M | 5.33M | 8.96M |
France | - | - | 797K | 852K | 898K |
Belgium | - | - | 228K | 157K | 176K |
Other (EU) | - | - | 5K | - | - |
Spain | 8K | 15.4K | 5.17K | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 56 | 01/01/2013 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 56 | 01/01/2013 |
Flavio Corpina
BRD | Director/Board Member | 47 | 01/01/2017 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.45% | -5.11% | -9.35% | +8.78% | 11.03M | ||
| +2.52% | +8.11% | +90.85% | +132.54% | 1,057B | ||
| +0.77% | +2.04% | +49.36% | +50.79% | 625B | ||
| +0.04% | -0.31% | +23.01% | +61.35% | 435B | ||
| +1.58% | +4.80% | +51.48% | +39.79% | 363B | ||
| +0.65% | +1.85% | +32.06% | +39.99% | 296B | ||
| +0.79% | +4.26% | +8.64% | +7.42% | 249B | ||
| +0.88% | +8.73% | +44.49% | +57.19% | 222B | ||
| +0.34% | +1.27% | -5.10% | -50.94% | 209B | ||
| +0.36% | +1.55% | +10.55% | +66.48% | 165B | ||
| Average | +0.61% | +0.67% | +29.60% | +41.34% | 362.08B | |
| Weighted average by Cap. | +1.04% | +1.33% | +49.10% | +66.20% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















